Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Eric J Topol. At the beginning of the COVID-19 pandemic, analog tools such as nasopharyngeal swabs for PCR tests were center stage and the major prevention tactics of masking and physical ...

  2. Eric J. Topol, M.D. Voted as the #1 Most Influential Physician Executive in the United States in 2012 in a national poll conducted by Modern Healthcare, Dr. Topol works on genomic and wireless digital innovative technologies to reshape the future of medicine. He is a practicing cardiologist at Scripps in La Jolla, California and widely credited ...

  3. Eric Topol is professor, molecular medicine, executive vice-president of Scripps Research, and founder and director of its Scripps Research Translational Institute. He has published over 1,300 peer-reviewed articles, with more than 300,000 citations, was elected to the National Academy of Medicine, and is one of the top 10 most cited ...

  4. Eric Topol is the founder and director of the Scripps Research Translational Institute, professor of Molecular Medicine and Executive Vice President of Scripps Research. He has published over 1,200 peer-reviewed articles, with more than 300,000 citations, been elected to the National Academy of Medicine, and is one of the top 10 most cited ...

  5. 27 de mar. de 2014 · Eric Topol is Professor of Genomics at the Scripps Research Institute, and the Founder and Director of the Scripps Translational Science Institute (STSI). As a researcher, he has published over 1100 peer-reviewed articles, with more than 170,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited ...

  6. Facts, data, and analytics about biomedical matters. Click to read Ground Truths, a Substack publication with hundreds of thousands of subscribers.

  7. Eric Topol has published over 1300 peer-reviewed articles, with more than 300,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine. His principal scientific focus has been on the use of genomic and digital data, along with artificial intelligence, to individualize medicine.